Mylan deal may skirt new IRS/Treasury inversion rules
September 23, 2014 at 12:49 PM EDT
Some unknowns loom but Pittsburgh-area pharmaceuticals company Mylan Inc.’s pending inversion deal appears poised to glide past new measures by the Obama administration to curb such transactions, analysts believe...